Viola Ng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Viola Ng has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Wan
Department of Pathology and Laboratory Medicine, University of British Columbia, and BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada.
1 shared publication - Angela Burleigh
British Columbia Cancer Agency, Vancouver, BC V5Z4E6, Canada
1 shared publication - Carlos Caldas
Department of Clinical Biochemistry and Institute of Metabolic Science, School of Clinical Medicine, University of Cambridge, Cambridge, UK
1 shared publication - Connie J. Eaves
Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, Canada
1 shared publication - Damian Yap
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
1 shared publication - J. Carl. Barrett
AstraZeneca, Boston, MA
1 shared publication
Latest Publications
- Open Access
- 9 January 2015
- Published by Springer Nature in Breast Cancer Research
- Vol. 17 (1) , 4
A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation
Introduction: The extracellular signals regulating mammary epithelial cell growth are of relevance to understanding the pathophysiology of mammary epithelia, yet they remain poorly characterized. In this study, we applied an unbiased approach to understanding the functional role of signalling molecules in several models of normal physiological growth and translated these results to the biological understanding of breast cancer subtypes.Methods: We developed and utilized a cytogenetically normal clonal line ofhTERTimmortalized human mammary epithelial cells in a fibroblast-enhanced co-culture assay to conduct a genome-wide small interfering RNA (siRNA) screen for evaluation of the functional effect of silencing each gene. Our selected endpoint was inhibition of growth. In rigorous postscreen validation processes, including quantitative RT-PCR, to ensure on-target silencing, deconvolution of pooled siRNAs and independent confirmation of effects with lentiviral short-hairpin RNA constructs, we identified a subset of genes required for mammary epithelial cell growth. Using three-dimensional Matrigel growth and differentiation assays and primary human mammary epithelial cell colony assays, we confirmed that these growth effects were not limited to the 184-hTERTcell line. We utilized the METABRIC dataset of 1,998 breast cancer patients to evaluate both the differential expression of these genes across breast cancer subtypes and their prognostic significance.Results: We identified 47 genes that are critically important for fibroblast-enhanced mammary epithelial cell growth. This group was enriched for several axonal guidance molecules and G protein–coupled receptors, as well as for the endothelin receptorPROCR. The majority of genes (43 of 47) identified in two dimensions were also required for three-dimensional growth, withHSD17B2,SNNandPROCRshowing greater than tenfold reductions in acinar formation. Several genes, includingPROCRand the neuronal pathfinding moleculesEFNA4andNTN1, were also required for proper differentiation and polarization in three-dimensional cultures. The 47 genes identified showed a significant nonrandom enrichment for differential expression among 10 molecular subtypes of breast cancer sampled from 1,998 patients.CD79A,SERPINH1,KCNJ5andTMEM14Cexhibited breast cancer subtype–independent overall survival differences.Conclusion: Diverse transmembrane signals are required for mammary epithelial cell growth in two-dimensional and three-dimensional conditions. Strikingly, we define novel roles for axonal pathfinding receptors and ligands and the endothelin receptor in both growth and differentiation.
- 9 January 2015
- Published by Springer Nature in Breast Cancer Research
- Vol. 17 (1) , 4
Open AccessA co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation
Introduction: The extracellular signals regulating mammary epithelial cell growth are of relevance to understanding the pathophysiology of mammary epithelia, yet they remain poorly characterized. In this study, we applied an unbiased approach to understanding the functional role of signalling molecules in several models of normal physiological growth and translated these results to the biological understanding of breast cancer subtypes.Methods: We developed and utilized a cytogenetically normal clonal line ofhTERTimmortalized human mammary epithelial cells in a fibroblast-enhanced co-culture assay to conduct a genome-wide small interfering RNA (siRNA) screen for evaluation of the functional effect of silencing each gene. Our selected endpoint was inhibition of growth. In rigorous postscreen validation processes, including quantitative RT-PCR, to ensure on-target silencing, deconvolution of pooled siRNAs and independent confirmation of effects with lentiviral short-hairpin RNA constructs, we identified a subset of genes required for mammary epithelial cell growth. Using three-dimensional Matrigel growth and differentiation assays and primary human mammary epithelial cell colony assays, we confirmed that these growth effects were not limited to the 184-hTERTcell line. We utilized the METABRIC dataset of 1,998 breast cancer patients to evaluate both the differential expression of these genes across breast cancer subtypes and their prognostic significance.Results: We identified 47 genes that are critically important for fibroblast-enhanced mammary epithelial cell growth. This group was enriched for several axonal guidance molecules and G protein–coupled receptors, as well as for the endothelin receptorPROCR. The majority of genes (43 of 47) identified in two dimensions were also required for three-dimensional growth, withHSD17B2,SNNandPROCRshowing greater than tenfold reductions in acinar formation. Several genes, includingPROCRand the neuronal pathfinding moleculesEFNA4andNTN1, were also required for proper differentiation and polarization in three-dimensional cultures. The 47 genes identified showed a significant nonrandom enrichment for differential expression among 10 molecular subtypes of breast cancer sampled from 1,998 patients.CD79A,SERPINH1,KCNJ5andTMEM14Cexhibited breast cancer subtype–independent overall survival differences.Conclusion: Diverse transmembrane signals are required for mammary epithelial cell growth in two-dimensional and three-dimensional conditions. Strikingly, we define novel roles for axonal pathfinding receptors and ligands and the endothelin receptor in both growth and differentiation.